Literature DB >> 29263074

Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts In Vitro Antimalarial Activity.

Susan A Charman1, Darren J Creek1, Carlo Giannangelo2, Lukas Stingelin2, Tuo Yang3, Leann Tilley3.   

Abstract

The peroxide bond of the artemisinins inspired the development of a class of fully synthetic 1,2,4-trioxolane-based antimalarials, collectively known as the ozonides. Similar to the artemisinins, heme-mediated degradation of the ozonides generates highly reactive radical species that are thought to mediate parasite killing by damaging critical parasite biomolecules. We examined the relationship between parasite dependent degradation and antimalarial activity for two ozonides, OZ277 (arterolane) and OZ439 (artefenomel), using a combination of in vitro drug stability and pulsed-exposure activity assays. Our results showed that drug degradation is parasite stage dependent and positively correlates with parasite load. Increasing trophozoite-stage parasitemia leads to substantially higher rates of degradation for both OZ277 and OZ439, and this is associated with a reduction in in vitro antimalarial activity. Under conditions of very high parasitemia (∼90%), OZ277 and OZ439 were rapidly degraded and completely devoid of activity in trophozoite-stage parasite cultures exposed to a 3-h drug pulse. This study highlights the impact of increasing parasite load on ozonide stability and in vitro antimalarial activity and should be considered when investigating the antimalarial mode of action of the ozonide antimalarials under conditions of high parasitemia.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Plasmodium falciparum; antimalarial activity; artefenomel; arterolane; ozonide; peroxide antimalarial; stability

Mesh:

Substances:

Year:  2018        PMID: 29263074      PMCID: PMC5826100          DOI: 10.1128/AAC.01566-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  64 in total

Review 1.  Bioavailable iron and heme metabolism in Plasmodium falciparum.

Authors:  P F Scholl; A K Tripathi; D J Sullivan
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

2.  Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes.

Authors:  Yuxiang Dong; Jacques Chollet; Hugues Matile; Susan A Charman; Francis C K Chiu; William N Charman; Bernard Scorneaux; Heinrich Urwyler; Josefina Santo Tomas; Christian Scheurer; Christopher Snyder; Arnulf Dorn; Xiaofang Wang; Jean M Karle; Yuanqing Tang; Sergio Wittlin; Reto Brun; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

3.  In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum.

Authors:  Sandra Hofer; Reto Brun; Sonja Maerki; Hugues Matile; Christian Scheurer; Sergio Wittlin
Journal:  J Antimicrob Chemother       Date:  2008-07-30       Impact factor: 5.790

4.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

5.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

6.  Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial.

Authors:  Neena Valecha; Srivicha Krudsood; Noppadon Tangpukdee; Sanjib Mohanty; S K Sharma; P K Tyagi; Anupkumar Anvikar; Rajesh Mohanty; B S Rao; A C Jha; B Shahi; Jai Prakash Narayan Singh; Arjun Roy; Pawandeep Kaur; Monica Kothari; Shantanu Mehta; Anirudh Gautam; Jyoti K Paliwal; Sudershan Arora; Nilanjan Saha
Journal:  Clin Infect Dis       Date:  2012-05-14       Impact factor: 9.079

7.  Spread of artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Elizabeth A Ashley; Mehul Dhorda; Rick M Fairhurst; Chanaki Amaratunga; Parath Lim; Seila Suon; Sokunthea Sreng; Jennifer M Anderson; Sivanna Mao; Baramey Sam; Chantha Sopha; Char Meng Chuor; Chea Nguon; Siv Sovannaroth; Sasithon Pukrittayakamee; Podjanee Jittamala; Kesinee Chotivanich; Kitipumi Chutasmit; Chaiyaporn Suchatsoonthorn; Ratchadaporn Runcharoen; Tran Tinh Hien; Nguyen Thanh Thuy-Nhien; Ngo Viet Thanh; Nguyen Hoan Phu; Ye Htut; Kay-Thwe Han; Kyin Hla Aye; Olugbenga A Mokuolu; Rasaq R Olaosebikan; Olaleke O Folaranmi; Mayfong Mayxay; Maniphone Khanthavong; Bouasy Hongvanthong; Paul N Newton; Marie A Onyamboko; Caterina I Fanello; Antoinette K Tshefu; Neelima Mishra; Neena Valecha; Aung Pyae Phyo; Francois Nosten; Poravuth Yi; Rupam Tripura; Steffen Borrmann; Mahfudh Bashraheil; Judy Peshu; M Abul Faiz; Aniruddha Ghose; M Amir Hossain; Rasheda Samad; M Ridwanur Rahman; M Mahtabuddin Hasan; Akhterul Islam; Olivo Miotto; Roberto Amato; Bronwyn MacInnis; Jim Stalker; Dominic P Kwiatkowski; Zbynek Bozdech; Atthanee Jeeyapant; Phaik Yeong Cheah; Tharisara Sakulthaew; Jeremy Chalk; Benjamas Intharabut; Kamolrat Silamut; Sue J Lee; Benchawan Vihokhern; Chanon Kunasol; Mallika Imwong; Joel Tarning; Walter J Taylor; Shunmay Yeung; Charles J Woodrow; Jennifer A Flegg; Debashish Das; Jeffery Smith; Meera Venkatesan; Christopher V Plowe; Kasia Stepniewska; Philippe J Guerin; Arjen M Dondorp; Nicholas P Day; Nicholas J White
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

8.  First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials.

Authors:  Joerg J Moehrle; Stephan Duparc; Christoph Siethoff; Paul L M van Giersbergen; J Carl Craft; Sarah Arbe-Barnes; Susan A Charman; Maria Gutierrez; Sergio Wittlin; Jonathan L Vennerstrom
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

9.  Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum.

Authors:  Jigang Wang; Chong-Jing Zhang; Wan Ni Chia; Cheryl C Y Loh; Zhengjun Li; Yew Mun Lee; Yingke He; Li-Xia Yuan; Teck Kwang Lim; Min Liu; Chin Xia Liew; Yan Quan Lee; Jianbin Zhang; Nianci Lu; Chwee Teck Lim; Zi-Chun Hua; Bin Liu; Han-Ming Shen; Kevin S W Tan; Qingsong Lin
Journal:  Nat Commun       Date:  2015-12-22       Impact factor: 14.919

10.  Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.

Authors:  Aung Pyae Phyo; Podjanee Jittamala; François H Nosten; Sasithon Pukrittayakamee; Mallika Imwong; Nicholas J White; Stephan Duparc; Fiona Macintyre; Mark Baker; Jörg J Möhrle
Journal:  Lancet Infect Dis       Date:  2015-10-05       Impact factor: 25.071

View more
  5 in total

1.  Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum.

Authors:  Geoffrey W Birrell; Matthew P Challis; Amanda De Paoli; Dovile Anderson; Shane M Devine; Gavin D Heffernan; David P Jacobus; Michael D Edstein; Ghizal Siddiqui; Darren J Creek
Journal:  Mol Cell Proteomics       Date:  2019-12-13       Impact factor: 5.911

2.  Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance.

Authors:  Xinsong Li; Leann Tilley; Yawei Du; Carlo Giannangelo; Wei He; Gerald J Shami; Wenya Zhou; Tuo Yang; Darren J Creek; Con Dogovski
Journal:  Antimicrob Agents Chemother       Date:  2022-04-13       Impact factor: 5.938

3.  System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion.

Authors:  Carlo Giannangelo; Ghizal Siddiqui; Amanda De Paoli; Bethany M Anderson; Laura E Edgington-Mitchell; Susan A Charman; Darren J Creek
Journal:  PLoS Pathog       Date:  2020-06-26       Impact factor: 6.823

4.  Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells.

Authors:  Ghizal Siddiqui; Carlo Giannangelo; Amanda De Paoli; Anna Katharina Schuh; Kim C Heimsch; Dovile Anderson; Timothy G Brown; Christopher A MacRaild; Jianbo Wu; Xiaofang Wang; Yuxiang Dong; Jonathan L Vennerstrom; Katja Becker; Darren J Creek
Journal:  ACS Infect Dis       Date:  2022-01-05       Impact factor: 5.084

5.  Exogenous Iron Increases Fasciocidal Activity and Hepatocellular Toxicity of the Synthetic Endoperoxides OZ78 and MT04.

Authors:  Karin Brecht; Carla Kirchhofer; Jamal Bouitbir; Francesca Trapani; Jennifer Keiser; Stephan Krähenbühl
Journal:  Int J Mol Sci       Date:  2019-10-01       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.